Health Testimony

Health Practice Council testimony to the House Ways and Means Subcommittee on Health regarding the 2011 Medicare Trustees Report. (June 22, 2011)
Community Living Assistance Services and Supports (CLASS) Act Task Force testimony to the U.S. House Committee on Energy and Commerce Subcommittee on Health regarding the CLASS program. (March 17, 2011)
State Health Committee testimony to the Massachusetts Legislature outlining some of the potential unintended consequences associated with H.B. 3447, An Act Providing for Equitable Coverage in Disability Policies, which would prohibit gender distinct premiums for disability insurance policies. (February 4, 2010)
State Health Committee testimony to the NAIC outlining several issues that need to be addressed, in terms of implementation at the state level, if federal health care reform is enacted. (December 4, 2009)
Health Practice Council testimony to the U.S. House Committee on Ways and Means outlining three criteria to ensure that the current markets remain viable, and offering comments on how certain provisions of the Tri-Committee bill conform with those criteria. (June 24, 2009)
Health Practice Council testimony to the House Ways and Means Committee on three actuarial principles that should be considered when determining whether health reform proposals will lead to improved insurance markets with greater access and affordability. (April 22, 2009)
Health Practice Council testimony to National Conference of Insurance Legislators (NCOIL) at a meeting about dependent health benefits. (July 11, 2008)
State Health Committee testimony, and related slide presentation, discussing rising health care costs in the context of health reform proposals to address the problem of the uninsured, including some of the drivers of costs and the considerations necessary to assess the impact of any potential cost control measure. (May 30, 2008)
Medical Reinsurance Work Group testimony to House Small Business Committee on increasing competition, reducing costs, and expanding small business health insurance coverage using the private reinsurance market. (May 24, 2007)
Committee on Federal Health Issues testimony outlining several key factors for consideration in the debate over the proper regulation of genetic information especially with respect to health insurance.
(July 22, 2004)